Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): Interactions with reproductive status

Nutritional Neuroscience

Volumn 13, Issue 4, 2010, Pages 161-169

  Davis, Paul F ^a   Ozias, Marlies K ^a   Carlson, Susan E ^b,c   Reed, Gregory A ^a   Winter, Michelle K ^a,c   McCarson, Kenneth E ^a,c   Levant, Beth ^a,c  

^a Sanofi Research Division   (United States)

^b Department of Dietetics and Nutrition ^*  (Australia)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

docosahexaenoic acid; dopamine receptor; omega 3; polyunsaturated fatty acid; postpartum; rat

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; LINOLENIC ACID; DOPAMINE RECEPTOR; ESTRADIOL; FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ANHEDONIA; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; ESTRADIOL BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; LIPID COMPOSITION; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REPRODUCTION; ANIMAL; BASAL GANGLION; BLOOD; BRAIN LEVEL; CHEMISTRY; DEPRESSION, POSTPARTUM; DIET; LONG EVANS RAT; MALE; PARITY; PHYSIOLOGY; PREGNANCY; PUERPERIUM;

ALPHA-LINOLENIC ACID; ANIMALS; BASAL GANGLIA; BRAIN CHEMISTRY; CAUDATE NUCLEUS; DEPRESSION, POSTPARTUM; DIET; DOCOSAHEXAENOIC ACIDS; ESTRADIOL; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FEMALE; MALE; PARITY; PHOSPHOLIPIDS; POSTPARTUM PERIOD; PREGNANCY; RATS; RATS, LONG-EVANS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REPRODUCTION;

EID: 77955185130     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683010X12611460764282     Document Type: Article

References (67)

1. Salem Jr N, Litman B, Kim H-Y et al. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 2001; 36: 945-960.
2. Horrocks LA, Farooqui AA. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 361-372.
3. Sinclair AJ. Long chain polyunsaturated fatty acids in the mammalian brain. Proc Nutr Soc 1975; 34: 287-291.
4. Clandinin MT, Chappell JE, Leong S et al. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 1980; 4: 131-138. (Pubitemid 10064581)
5. Clandinin MT, Chappell JE, Leong S et al. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980; 4: 121-129. (Pubitemid 10064580)
6. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 329-349.
7. Salem Jr N, Moriguchi T, Greiner RS et al. Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids. J Mol Neurosci 2001; 16: 299-307.
8. Merikangas KR, Herrell R. Contributions of epidemiology to the neurobiology of mental illness. In: Charney DS, Nestler EJ. (eds) Neurobiology of Mental Illness. Oxford: Oxford University Press, 2004; 103-111.
9. Burt VK, Stein K. Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002; 63 (Suppl 7): 9-15.
10. McNamara RK, Hahn CG, Jandacek R et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007; 62: 17-24.
11. Edwards R, Peet M, Shay J et al. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998; 48: 149-155. (Pubitemid 28244216)
12. Maes M, Christophe A, Delanghe J et al. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999; 85: 275-291.
13. Tiemeier H, van Tuijl HR, Hofman A et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003; 78: 40-46.
14. Peet M, Murphy B, Shay J et al. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998; 43: 315-319. (Pubitemid 28137622)
15. Schiepers OJ, de Groot RH, Jolles J et al. Plasma phospholipid fatty acid status and depressive symptoms: association only present in the clinical range. J Affect Disord 2009; 18: 209-214.
16. Mamalakis G, Kalogeropoulos N, Andrikopoulos N et al. Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr 2006; 60: 882-888.
17. Tanskanen A, Hibbeln JR, Tuomilehto J et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 2001; 52: 529-531.
18. Appleton KM, Woodside JV, Yarnell JW et al. Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle? J Affect Disord 2007; 104: 217-223.
19. Astorg P, Couthouis A, Bertrais S et al. Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women. Prostaglandins Leukot Essent Fatty Acids 2008; 78: 171-182.
20. Fitten LJ, Ortiz F, Fairbanks L et al. Depression, diabetes and metabolic-nutritional factors in elderly Hispanics. J Nutr Health Aging 2008; 12: 634-640.
21. Freeman MP, Hibbeln JR, Wisner KL et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006; 67: 1954-1967.
22. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002; 69: 15-29.
23. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 2003; 73: 3181-3187.
24. Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 237-243.
25. Freeman MP, Hibbeln JR, Wisner KL et al. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006; 113: 31-35.
26. Rees AM, Austin MP, Owen C et al. Omega-3 deficiency associated with perinatal depression: case control study. Psychiatry Res 2009; 166: 254-259.
27. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64: 327-337.
28. 2-like receptors and the antidepressant response. Biol Psychiatry 2007; 61: 145-153.
29. Aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. Can Med Assoc J 2009; 180: 305-313.
30. Nestler EJ, Carlezon Jr WA. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151-1159.
31. Post RM, Kotin J, Goodwin FK et al. Psychomotor activity and cerebrospinal fluid metabolites in affective illness. Am J Psychiatry 1973; 130: 67-72.
32. Roy A, Karoum F, Pollack S. Marked reduction in indexes of dopamine transmission among patients with depression who attempted suicide. Arch Gen Psychiatry 1992; 49: 447-450.
33. Reddy PL, Khanna S, Subash MN et al. CSF amino metabolites in depression. Biol Psychiatry 1992; 31: 112-118.
34. Brown RG, Gershon S. Dopamine and depression. J Neural Trans 1993; 91: 75-109.
35. Van Praag HM, Korf J, Lakke J et al. Dopamine metabolism in depression, psychoses, and Parkinson's disease: the problem of specificity of biological variables in behavior disorders. Psychol Med 1975; 4: 21-29.
36. Guze BH, Barrio JC. The etiology of depression in Parkinson's disease patients. Psychosomatics 1991; 32: 390-394.
37. Harvey PO, Pruessner J, Czechowska Y et al. Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Mol Psychiatry 2007; 12: 703, 767-775.
38. Levant B, Radel JD, Carlson SE. Reduced brain DHA content after a single reproductive cycle in female rats fed a diet deficient in n-3 polyunsaturated fatty acids. Biol Psychiatry 2006; 60: 987-990.
39. Levant B, Ozias MK, Carlson SE. Diet (n-3) polyunsaturated fatty acid content and parity interact to alter maternal rat brain phospholipid fatty acid composition. J Nutr 2006; 136: 2236-2242.
40. Levant B, Ozias MK, Davis PF et al. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 2008; 33: 1279-1292.
41. Pliakas AM, Carlson RR, Neve RL et al. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 2001; 21: 7397-7403.
42. Charney DS, Manji HK. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004; 2004: re5.
43. Krishnan V, Han MH, Graham DL et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007; 131: 391-404.
44. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902.
45. Guillin O, Diaz J, Carroll P et al. BDNF controls dopamine D3 receptor expression and triggers behavioral sensitization. Nature 2001; 411: 86-89.
46. 1 dopamine receptors. J Neurochem 2007; 100: 416-428.
47. Green P, Yavin E. Fatty acid composition of late embryonic and early postnatal rat brain. Lipids 1996; 31: 859-865.
48. Makrides M, Neumann MA, Byard RW et al. Fatty acid composition of brain, retina, and erythrocytes in breast-and formula-fed infants. Am J Clin Nutr 1994; 60: 189-194.
49. Miller LJ. Postpartum depression. JAMA 2002; 287: 762-765.
50. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. J Neurochem 1966; 13: 655-669.
51. Reeves PG, Nielsen FH, Fahey Jr GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-1951.
52. Levant B, Ozias MK, Jones KA et al. Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain. Lipids 2006; 41: 407-414.
53. Levant B. Dopamine receptor binding and quantitative autoradiographic study. In: Wang JQ. (ed) Drugs of Abuse Neurological Reviews and Protocols. Totowa, NJ: Humana, 2003; 297-314.
54. Bylund DB, Yamamura HI. Methods for receptor binding. In: Yamamura H, Enna S, Kuhar M. (ed) Methods in Neurotransmitter Receptor Analysis. New York: Raven, 1990; 1-36.
55. 3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study. Neuropsychopharmacology 1998; 18: 305-316.
56. McCarson KE, Krause JE. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J Neurosci 1994; 14: 712-720.
57. Duric V, McCarson KE. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 2005; 133: 999-1006.
58. Galli C, Trzeciak HI, Paoletti R. Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride: reciprocal replacement of n-6 and n-3 polyunsaturated fatty acids. Biochim Biophys Acta 1971; 248: 449-454.
59. 11C]raclopride PET. Psychopharmacology (Berl) 2008; 197: 581-590.
60. Papp M, Klimek V, Willner P. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) 1994; 115: 441-446.
61. 2 receptor mRNA. Neuroreport 2007; 18: 1039-1043.
62. Yaroslavsky I, Colletti M, Jiao X et al. Strain differences in the distribution of dopamine (DA-2 and DA-3) receptor sites in rat brain. Life Sci 2006; 79: 772-776.
63. Kram ML, Kramer GL, Ronan PJ et al. Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26: 639-645.
64. Novick A, Yaroslavsky I, Tejani-Butt S. Strain differences in the expression of dopamine D1 receptors in Wistar-Kyoto (WKY) and Wistar rats. Life Sci 2008; 83: 74-78.
65. 11C]SCH 23,390 in patients with major depression with anger attacks. Depress Anxiety 2006; 23: 175-177.
66. 11C]NNC-112. Neuropsychopharmacology 2009; 34: 1277-1287.
67. 2 antagonists, ritanserin, and setoperone. Psychopharmacol Ser 1987; 3: 214-224.